[AMRX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
06-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 25.18%
YoY- 96.61%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 535,075 493,105 510,034 519,294 464,662 498,533 397,328 21.97%
PBT 34,824 14,904 -5,477 -21,889 -21,758 13,344 -57,111 -
Tax 2,648 359 1,485 144 2,186 -108,173 7,792 -51.33%
NP 14,532 6,706 -3,037 -8,975 -11,996 115,067 -32,128 -
Tax Rate -7.60% -2.41% - - - 810.65% - -
Total Cost 520,543 486,399 513,071 528,269 476,658 383,466 429,456 13.69%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 2.72 1.36 -0.60 -1.73 -2.58 23.08 -8.09 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS 0.10 0.05 -0.02 -0.06 -0.08 0.78 -0.23 -
EPS Diluted 0.10 0.04 -0.02 -0.06 -0.08 0.78 -0.23 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.